2020 China Ophthalmic Market Report: A Regional Analysis for 2019 to 2025
発行: Market Scope, LLC
The new "2020 China Ophthalmic Market Report" features updated forecasts that reflect the effect of COVID-19 on the ophthalmic market. The report also includes updated cataract treatment opportunity analysis, discussion of new policies and regulations, profiles of 10 non-public eye hospital chains, and evaluation of new acquisitions by Chinese companies. In addition, the report features more detailed dry eye treatment forecasts, fueled by a new dry eye disease model.
The "2020 China Ophthalmic Market Report" is the leading industry source for accurate and relevant information on all aspects of the Chinese ophthalmic market. Our report includes a comprehensive overview of the Chinese population and economic conditions. The report covers prevalence of and forecasts for eye diseases and conditions and discusses therapeutic approaches, including commercialized and pipeline products.
The report looks at the market's evolution and forecasts growth over the next five years for 10 segments: cataract, refractive, glaucoma, retina, dry eye, other ophthalmic drugs, diagnostic equipment, multipurpose ophthalmic lasers (exclusive of femtosecond and excimer), single-use surgical devices, and surgical instruments. Each segment includes an analysis of competitors, estimated installed base, and a five-year forecast of market performance.
The following information is also included:
Market Scope has prepared this report for individuals and companies participating in China's ophthalmic market: ophthalmologists, surgeons, hospitals, clinics, manufacturers, distributors, market analysts, industry investors, and anyone else with an interest in the business of ophthalmology in China. The author of this report, Peter Downs, continues to spend significant time in China to better understand the complexities and challenges of this rapidly changing market. This presence greatly impacts the quality of our reporting.
Market Scope's industry reports are meticulously prepared by a dedicated team of in-house analysts with over 100 years of collective ophthalmic market research experience. Each data point is driven by a combination of sources, including the following: